美国FDA 医疗器械体系法规QSR820（中英文版）

VIP免费

多多猪 2025-10-16 5 706.03KB 32 页

侵权投诉

美国 FDA 医疗器械体系法规 QSR820 (中文版)

Part 820——质量体系法规——目录

Subpart A- 总则

820.1

820.3

820.5

范围

定义

质量体系

Subpart B-质量体系要求

820.20

820.22

820.25

管理职责

质量审核

人员

Subpart C- 设计控制

820.30 设计控制

Subpart D- 文件控制

820.40 文件控制

Subpart E- 采购控制

820.50 采购控制

Subpart F- 标识与可追溯性

820.60 标识

820.65 可追溯性

Subpart G- 生产和过程控制

820.70 生产和过程控制

820.72 检验、测量和试验设备

820.75 过程确认

Subpart H- 验收活动：

820.80 进货、过程和成品器械检验

820.86 检验状态

Subpartl- 不合格品

820.90 不合格品

Subpart J- 纠正和预防措施

820.100 纠正和预防措施

Subpart K- 标识和包装控制

820.120 设备标签

820.130 设备包装

Subpart L- 搬运/储存/分销和安装

820.140

820.150

820.160

820.170

搬运

贮存

分销

安装

Subpart L- 记录

820.180 记录的通用要求

820.181 设备主要记录

820.184 设备历史记录

820.186 质量体系记录

820.198 投诉文件

Subpart M- 服务

820.200 服务

Subpart N- 统计技术

820.250 统计技术

Subpart A——总则

Subpart A--General Provisions

Sec.820.1 范围

Sec.820.1 Scope.

(a) 适用性Applicability。

(1)本质量体系法规阐明了当前良好制造法规 Current good manufacturing practice

(CGMP) 的要求。本标准适用于所有预期用于人类的成品器械的设计、制造、包装、标识、

储存、安装和服务中所使用的管理方法、设施和控制。本标准的目的是保证成品器械的安全

性和有效性，并符合联邦食品、药品和化妆品法案Federal Food,Drag and Cosmetic Act

(the act)。本法规适用于所有的医疗器械成品制造商。如果制造商仅从事本部分有要求服

从的某些过程而未从事其它过程，则只需符合其实施的过程的要求。对于I类设备，设计控

制仅适用于Sec.820.30(a)(2) 中列出的设备。本法规不适用于成品器械的部件或零件

制造商，但鼓励这类制造商把本法规的适当规定作为指南来使用。人血和血液成分制造商不

受本部分法规的限制，但应遵循本章606部分法规的要求。

Current good manufacturing practice(CGMP)requirements are set forth in this quality system

regulation.The requirements in this part govern the methods used in,and the facilities and

controls used for,the design,manufacture,packaging,labeling,storage,installation,and

servicing of all finished devices intended for human use.The requirements in this part are

intended to ensure that finished devices will be safe and effective and otherwise in compliance

with the Federal Food,Drug,and Cosmetic Act(the act).This part establishes basic

requirements applicable to manufacturers of finished medical devices.If a manufacturer

engagesin only some operations subject to the requirements in this part,and not in others,

that manufacturer need only comply with those requirements applicable to the operations in

which it is engaged.With respect to class I devices,design controls apply only to those

devices listed in 820.30(a)This regulation does not apply to manufacturers of components or

parts of finished devices,but such manufacturers are encouraged to use appropriate

provisions of this regulation as guidance.Manufacturers of human blood and blood

components are not subject to this part,but are subject to part 606 of this chapter.

Manufacturers of human cells,tissues,and cellular and tissue-based products(HCT/Ps),as

defined in 1271..3(d)of this chapter,that are medical devices (subject to premarket review or

notification,or exempt from notification,under an application submitted under the device

provisions of the act or under a biological product license application under section 351 of the

Public Health Service Act)are subject to this part and are also subject to the donor-eligibility

procedures set forth in part 1271 subpart C of this chapter and applicable current good tissue

practice procedures in part 1271 subpart D of this chapter.In the event of a conflict between

applicable regulations in part 1271 and in other parts of this chapter,the regulation specifically

applicable to the device in question shall supersede the more general.

(2) 本部分的规定适用于本部分定义的预期用于人体的所有成品器械，不论其在美国(包

含：美国任何州或领土，哥伦比亚特区，波多黎各联邦)本土制造还是进口，提供进口的产品。

(2)The provisions of this part shall be applicable to any finished device as defined in this part,

intended for human use,that is manufactured,imported,or offered for import in any State or

Territory of the United States,the District of Columbia,or the Commonwealth of Puerto Rico.

(3)在本法规中“适用时”(where appropriate)出现过多次。当要求根据“where appropriate”

被认为是合格时，其要求应被认为是“适用的”(appropriate), 除非组织能提供文件证明其

理由。如果不执行预期结果会导致产品不符合其特定的要求，或组织不需要执行任何必要的

纠正措施，那么要求就是适用的 (appropriate)。

(3)In this regulation the term "where appropriate"is used several times.When a requirement

is qualified by "where appropriate,"it is deemed to be "appropriate"unless the manufacturer

can document justification otherwise. A requirement is "appropriate"if non-implementation

could reasonably be expected to resultin the product not meeting its specified requirements or

the manufacturer not being able to carry out any necessary corrective action.

(b) 限制。除非特别规定，则本部分质量体系法规是本章其它部分法规的补充要求。在

不能符合所有适用的法规，包括本章此部分和其它部分的情况，特别是对讨论中的设备，此

法规应取代其它通用要求。

(b)The quality system regulation in this part supplements regulations in other parts of this

chapter except where explicitly stated otherwise.In the event of a conflict between applicable

regulations in this part and in other parts of this chapter,the regulations specifically applicable

to the device in question shall supersede any other generally applicable requirements.

360i、360j、3601、370、374、381、383 中)501、502、510、513、514、515、518、

519、520、522、701、704、801、803下建立并发布的。不符合本部分 (Part 820) 的任

何适用的规定，依据法令section 501(h) 条款，可判定该产品为伪劣产品。这类产品及对

此不符合负责的任何个人，将依法被起诉。

(c)Authority.Part 820 is established and issued under authority of sections 501,502,510,513,

文档加载中……请稍候！
如果长时间未打开，您也可以点击刷新试试。

下载文档到电脑，查找使用更方便

立即下载 VIP免费下载

标签： #医疗器械 #FDA #QSR820

摘要：

美国FDA医疗器械体系法规QSR820(中文版)Part820——质量体系法规——目录SubpartA-总则820.1820.3820.5范围定义质量体系SubpartB-质量体系要求820.20820.22820.25管理职责质量审核人员SubpartC-设计控制820.30设计控制SubpartD-文件控制820.40文件控制SubpartE-采购控制820.50采购控制SubpartF-标识与可追溯性820.60标识820.65可追溯性SubpartG-生产和过程控制820.70生产和过程控制820.72检验、测量和试验设备820.75过程确认SubpartH-验收活动：820.80进货...

展开>> 收起<<

美国FDA 医疗器械体系法规QSR820（中英文版）.pdf

共32页,预览32页

还剩页未读，继续阅读

声明：如果您的权利被侵害，请联系我们的进行举报。

美国FDA 医疗器械体系法规QSR820（中英文版）

相关推荐

相关内容

热门标签

举报选择: